In a recent interview with LN+, cardiologist Jorge Tartaglione advocated for the use of statins as a crucial component in managing cholesterol levels. He explains that these medications work by inhibiting an enzyme that decreases cholesterol production in the liver, thereby reducing the risk of heart attacks, strokes, and neurodegenerative diseases like Alzheimer's and dementia. Tartaglione highlighted that while a healthy diet and regular exercise are beneficial for controlling cholesterol, they are often insufficient, and medication is necessary for many patients.

Tartaglione points out that only about 30% of cholesterol levels come from dietary sources, with the remainder often being produced genetically by the liver. This insight is particularly relevant for patients who maintain a vegetarian diet yet still experience high cholesterol levels, demonstrating the complexities of cholesterol management. The cardiologist's comments underscore the necessity of individualized treatment plans that may include statins, especially given the genetic factors at play for many individuals.

Additionally, Tartaglione expressed concern over the prevalence of misinformation regarding health and medicine, particularly related to cholesterol management and statin usage. He emphasized the need for reliable information and consulting healthcare professionals to combat the spread of false news that could endanger patients’ health. Overall, the discussion highlighted the significant role that statins can play in cholesterol management in conjunction with lifestyle modifications based on individual health profiles.